Since that time, people with MS have reported several additional benefits, including a reduction in fatigue
Healthcare provider consultation is advisable before use, particularly for individuals taking prescription medications
Clinical evidence compared Clinical data separates hype from reality
This widespread use of these popular weight loss drugs, both for approved diabetes treatment and off-label weight loss, has now resulted in thousands of patients reporting severe gastrointestinal injuries and vision loss, conditions that many allege were not adequately disclosed on warning labels when they began treatment
Gastrointestinal side effects, affecting up to 50% of GLP-1 users, significantly reduce treatment adherence
Mild fatigue or lethargy shortly after administration